Connect with us

Global Issues

The 340B Rebate Trap -By Fransiscus Nanga Roka

No national expansion will occur until regulators can ensure that the model does not adversely impact liquidity, access, staffing or patient care. This analysis should be its own independent, data-driven and public document. This drives the government by theory, not evidence which does not keep emergency departments open in practice.

Published

on

Fransiscus Nanga Roka - Indonesia

The battle between the American Hospital Association (AHA) and the federal effort to impose a Medicare/340B rebate model is not simply a technical issue regarding billing mechanics. It is a face-off as to who absorbs the financial hit that will follow U.S. drug pricing reform: safety-net hospitals or powerful manufacturers. And in that fight, the governments effort at rebates looks less like modernization than an outright risk shift.

The AHA (but on behalf of the safety-net hospitals) vs. HRSA, in front of the pharmaceutical industry’s rebate architecture by ideal design. Replaced upfront discounts with the use of post-sale rebates. By late 2025, tensions erupted into conflict which continued essentially unabated into 2026. Where? In federal court (the U.S. District Court for Maine, and the First Circuit). As the 340B program was intended to support care for poor, rural and medically underserved patients. At first, hospitals would pay the entire price upfront and then throw themselves on the mercy of a data-heavy claims process for reimbursement after the fact. That is the basic scandal: It pressures hospitals to act as if they were free lenders of cash to drug manufacturers.

The administration also argues that rebates deter abuse, limit overlap with Inflation Reduction Act pricing and accountability. However, brutal facts cannot be hidden behind policy slogans. Outfits with comfortable cash cushions or health systems with recurring debt make for difficult bedfellows, but most hospitals tend to operate in such a manner. They are operating emergency departments, behavioral health services (treating addiction), opioid treatment programs and community clinics all on razor-thin margins. The purpose of a rebate system is to push payment back so far as to be lethal for liquidity even if the nominal discount will ever materialise. Now in public finance timing is everything. Access can die between the delay and the pass.

The AHA’s challenge is strong, legally, because it focuses on the fundamental Administrative Procedure Act problem with the way this got rolled out. Such a radical change with huge budgetary implications cannot be pushed through because of an administration’s impatience. Agencies only explain themselves, balance reliance interests, and face evidence that their own policy may cause injury. The government cannot blithely discard the idea that switch costs are important, if it has built decades of operations on up front discounts among hospitals. That is not reform. That is bureaucratic amnesia.

The deeper issue is institutional. The rebate model has a perverse logic that means public hospitals, rural systems and safety-net providers arguably the weakest actors in health care are expected to bear the burden of policymakers’ experiments aimed at restraining stronger actors. That is upside-down governance. If Washington wishes to avoid gaming, it should go after gaming. If it wants price transparency, then, it ought to create a mechanism that does not require hospitals to write big checks and wait for pharmaceutical gatekeepers to approve repayment.

Advertisement

Ensure Initials Discounts for safety net providers

An upfront discount is actually not a procedural detail: it is the lifeblood that allows safety-net hospitals to purchase drugs now, and treat patients now. Switching them out for rebates requires hospitals to pay upfront, deal with the delay and take on the risk. That is particularly perilous to institutions that are already running on a knife edge of failure. In practice, the model instead makes lenders of hospitals (willing or otherwise), to drug companies.

And tie hospital cash flow mechanics to put in place and separate anti abuse enforcement from.

Policymakers should look to ensure that it no longer happens by going straight for the abuse through audits, verification and penalties. But they should not upend the entire payment system and penalize all safety-net providers for the misdeeds of a few. Enforcement belongs in compliance, not in the hospital operating budget.

Establish a fast dry dispute process for rebate claims

Advertisement

A rebate scheme absent of a swift dispute resolution mechanism is a bureaucratic dead-end. The money associated wtih life-saving medicines cannot take months as hospitals continue to pay vendors, staff and service provider costs. The system should have clear deadlines and evidence rules, provisional payment protection while claims are being assessed. Otherwise, it is a bauble of administrative order that is the same as nothing other than a shock to cash flow.

Exclude hospitals facing high burden obligations from any pilot model

The first places we should start testing this are low income and safety-net facilities, such as rural hospitals or trauma centers. They are both the least able to absorb uncertainty and the most likely to suffer immediate losses. Testing risk on fragile hospitals is not cautious innovation; it is policy experimentation on the most vulnerable institutions.

Deny any further national rollout without full impact analysis

No national expansion will occur until regulators can ensure that the model does not adversely impact liquidity, access, staffing or patient care. This analysis should be its own independent, data-driven and public document. This drives the government by theory, not evidence which does not keep emergency departments open in practice.

Advertisement

In one sentence: Defense of the safety net should be first, and an anti-police abuse program second initially not vice versa.

The moral is clear: a health policy improving the accounting but undermining care, are not smart reforms. A glacial hand-off of risk from pharmaceuticals to the institutions that make up the safety net. When the safety net is obligated to pay for a system that exists only in relation to it, it is not a technical failure of morals but an intersection. It is structural.

Fransiscus Nanga Roka

Faculty of Law University 17 August 1945 Surabaya and Managing Partner Law Firm Victorious Indonesia

Advertisement
Continue Reading
Advertisement
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Trending Contents

Topical Issues

Seyi-Tinubu Seyi-Tinubu
Breaking News2 days ago

Seyi Tinubu Threatens Legal Action Over Viral Statement on Father’s Presidency

Seyi Tinubu has threatened legal action against individuals behind a viral social media poster attributing a controversial statement about President...

Atiku Atiku
Breaking News2 days ago

Atiku Promises Fuel Subsidy Restoration, End to Insecurity Ahead of 2027 Election

ADC presidential candidate Atiku Abubakar promises to restore fuel and electricity subsidies, tackle insecurity and expand Kolmani oil exploration if...

Breaking News2 days ago

ADC Crisis: Nafiu Bala Seeks Reconciliation With Atiku, David Mark After Court Victory

ADC factional leader Nafiu Bala extends an olive branch to Atiku Abubakar and David Mark after a court ruling, calling...

Ex-President-Goodluck-Jonathan Ex-President-Goodluck-Jonathan
Breaking News2 days ago

Nigeria’s Development Hindered by Primitive Leadership Recruitment, Jonathan Warns

Former President Goodluck Jonathan says Nigeria cannot progress without ending religious and ethnic bias in leadership selection and prioritising competence...

Forgotten Dairies3 days ago

Love Is Not a Substitute for a Prenuptial Agreement: The Cross-Border Financial Risks Facing Nigerians Abroad -By Daniel Nduka Okonkwo

For a cross-border prenuptial agreement to have a realistic prospect of being respected, its preparation must go beyond obtaining signatures...

Seyi Makinde and Tinubu Seyi Makinde and Tinubu
Breaking News4 days ago

Makinde: Tinubu May Be Unhappy With Me Over 2027 Presidential Ambition

Seyi Makinde says his 2027 presidential ambition may have strained his relationship with Tinubu, revealing the President has not contacted...

Ladi Adebutu Ladi Adebutu
Breaking News4 days ago

2027 Elections: Court Directs INEC to Reinstate Adebutu as Ogun PDP Governorship Candidate

Court orders INEC to publish Oladipupo Adebutu as Ogun PDP governorship candidate within 24 hours, declaring his removal unlawful and...

Breaking News4 days ago

EFCC Trial: Witness Tells Court of Presidential Orders on NSITF Activities Under Ngige

EFCC witness Onwusoro Iheamelam testifies on presidential directives and NSITF procurement activities as the trial of former minister Chris Ngige...

Amupitan SAN INEC Amupitan SAN INEC
Breaking News4 days ago

Atiku’s 2027 Ambition: INEC Will Respect Supreme Court Decision on ADC Dispute – Amupitan

Amupitan says INEC will respect Supreme Court decisions on the ADC dispute, as over 300 election-related cases remain pending ahead...

Breaking News4 days ago

Attack on NDC Meeting: Obi Still Commands Strong Support Base, Doherty Tells Politicians

Funso Doherty says Peter Obi retains significant political influence after suspected thugs attacked an NDC town hall meeting in Lagos.